EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Neuroimmune pathophysiology of long COVID

Janna K Moen iD, Christopher A Baker iD, Akiko Iwasaki iD

Psychiatry and Clinical Neurosciences · 2025

DOI: 10.1111/pcn.13855 ↗

At a glance

Übersichtsarbeit in Psychiatry and Clinical Neurosciences, 2025. Written by Janna K Moen and 2 co-authors. Institution: Howard Hughes Medical Institute, Chevy Chase, Maryland, USA. Major MEDLINE topics: COVID-19, Neuroimmunomodulation, Nervous System Diseases, Peripheral Nervous System Diseases. Cited 39 times so far (Crossref); 342 references. The full text is freely available (open access, CC BY 4.0). Funded by: Howard Hughes Medical Institute, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Although COVID‐19 was originally considered a respiratory illness, it is now well established that SARS‐CoV‐2 infection can have far‐reaching impacts on the nervous system. Neurological symptoms such as chemosensory dysfunction are frequently observed during acute infection and approximately 10% of COVID‐19 cases will go on to develop new or persistent long‐term symptoms, a condition known in the literature as post‐acute symptoms of COVID‐19 (PASC) or by the patient‐coined term Long COVID. Common neurological symptoms in Long COVID include new onset cognitive difficulties, dysautonomia, fatigue, and peripheral neuropathy. The emergence of Long COVID has prompted renewed interest in the study of post‐acute infection syndromes (PAIS), particularly in the area of neuroimmune interactions. In this review we provide a comprehensive overview of the current body of literature on neurological manifestations of SARS‐CoV‐2 infection and Long COVID, with an emphasis on neuroimmune mechanisms drawn largely from autopsy studies and animal models. A more complete understanding of neuroimmune crosstalk in Long COVID will not only guide the development of therapies for this highly disabling condition but will also contribute to our general understanding of neuroimmune interactions in health and disease.

Subjects

MeSH terms (MEDLINE)

COVID-19NeuroimmunomodulationNervous System DiseasesPeripheral Nervous System DiseasesHumansPost-Acute COVID-19 SyndromeSARS-CoV-2AnimalsFatigue

Author keywords

biological psychiatrybrain and painimmunology and psychiatry

Authors and institutions

  • Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
  • Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Center for Infection and Immunity, Yale University School of Medicine, New Haven, Connecticut, USA.

ORCID profiles: Janna K Moen, Christopher A Baker, Akiko Iwasaki

Funding

  • Howard Hughes Medical Institute
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Cite

APA

Moen, J. K., Baker, C. A., & Iwasaki, A. (2025). Neuroimmune pathophysiology of long COVID. Psychiatry and Clinical Neurosciences. https://doi.org/10.1111/pcn.13855

Vancouver

Moen JK, Baker CA, Iwasaki A. Neuroimmune pathophysiology of long COVID. Psychiatry and Clinical Neurosciences. 2025. doi:10.1111/pcn.13855

BibTeX
@article{Moen2025,
  author = {Moen, Janna K and Baker, Christopher A and Iwasaki, Akiko},
  title = {Neuroimmune pathophysiology of long COVID},
  journal = {Psychiatry and Clinical Neurosciences},
  year = {2025},
  doi = {10.1111/pcn.13855}
}
Start for free →